08:23:47 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Medivolve Inc
Symbol MEDV
Shares Issued 405,288,865
Close 2022-04-05 C$ 0.055
Market Cap C$ 22,290,888
Recent Sedar Documents

Medivolve to host update call April 7

2022-04-05 17:10 ET - News Release

Mr. David Preiner reports

MEDIVOLVE TO HOST LIVE WEBINAR TO DISCUSS CORPORATE UPDATE

Medivolve Inc. will be hosting a corporate update presentation with analysts and investors via live webinar on Thursday, April 7, at 12 p.m. ET. Participants can register and submit questions on-line.

Specifically, the webinar will feature Medivolve's chief executive officer, David Preiner, and chief financial officer, Peter Michel, to discuss updates on the company's business developments as well as the recent financial results for the fourth quarter ended Dec. 31, 2021. Additionally, the company will be welcoming questions from participants, through the registration form. The company will endeavour to answer as many questions as possible.

The company confirms that subsequent to the press release dated March 31, 2022, there has been no material fact or material change of the company that has not been generally disclosed.

About Medivolve Inc.

Medivolve is a health care technology company that seeks to reinvent the U.S. health care system by leveraging a bespoke telehealth platform, a clinical diagnostic network and a data-driven artificial intelligence framework to improve patient care.

The company was born out of the health care crisis, to rethink, relearn and ultimately reimagine a better way for the health care system to operate. Its network of retail collection sites plays an essential role in recovery by giving all Americans access to fast, accurate and inexpensive clinical services when and where they need them. These centres will also play a pivotal role in diagnostic testing, vaccinations and other point-of-care services. The company is building disruptive technologies to make it easier and faster to identify, treat and prevent medical issues. In doing so, it is working to give patients a holistic and empowered view of their personal health.

The company's long-term mission is to permanently fix systemic issues in the nation's fragmented, overly complex and expensive health care system. Medivolve's next growth phase is about pivoting the model and putting the pieces together to build a profitable, software-as-a-service-based (SaaS) health tech company. Medivolve brings data-driven clinical diagnostics, physician recommendations and prescription medications directly to people, all powered by a singular, streamlined technology network. A powerful, singular purpose unites the company's team: harnessing the transformative power of technology to create healthier lives.

Underpinned by a bespoke, AI-driven (artificial intelligence) platform, the company is developing a stealth system that constantly gets smarter, takes the guesswork out of diagnostics and flags critical health issues immediately to deliver an unparalleled level of personalization for each patient. It is determined to push the boundaries of what is possible -- not just for its business and its shareholders, but for physicians and patients, and the future of health care. The company strives to achieve a continuity of care never seen before, a game changer for its business and patients in the communities the company serves.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.